Hexarelin

Batch #514367Batch #514367
Report #53448Report #53448
Tested at 6.20mgTested at 6.20mg
Size: 5mg
Visa Mastercard American Express Discover Apple Pay Google Pay
Ships by ...
Flag
FREE Shipping

RESEARCH USE ONLY
These compounds are NOT intended for human consumption, clinical use, or veterinary applications. We are not affiliated with any pharmaceutical companies or their commercial medications. By placing an order, you certify these materials will be used exclusively for in vitro testing and laboratory experimentation only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

About Hexarelin

Hexarelin is a synthetic peptide studied for its role in stimulating pathways associated with growth hormone release. Research has explored its interactions with metabolic processes cellular signaling and potential effects on biological systems particularly within the context of peptide activity in the endocrine system.

Product Specifications

Hexarelin Lyophilized Powder in 3ml vial.

Application

Research peptide with potential in growth hormone secretion and muscle wasting studies

Appearance

Solid, white powder in 3mL glass ampule

Chemical Formula
PubChem CID
CAS Number

208251-52-9

Molecular Weight

887.04 g/mol

Synonyms

Examorelin, Hexarelin Acetate

Storage

Store at ≤6°C, sealed, away from heat, light, and moisture.

Hexarelin Research

1. Clinical Overview 

Hexarelin is a synthetic growth hormone, releasing peptide that works to stimulate the release of the natural growth hormone (GH) secretion. The peptide exerts its effect on the (GHS-R1a) ghrelin receptor. Hence, once they are stimulated, more hormone is released and muscle-building, fat metabolism and heart functioning may be improved.

In addition to its effects on growth hormone release, hexarelin has shown potential in influencing other physiological processes. Studies suggest that it may help improve bone density, enhance energy levels, and support tissue repair by increasing the availability of GH and its downstream mediator, IGF-1 (Insulin-like Growth Factor 1).

 

2. Human Clinical Findings 

Six healthy young men were given either two or three daily subcutaneous injection of the peptide hexarelin at a dose of 1.5 micrograms/kg. The levels of hormone were determined every 20 minutes for 24 hours. 

Both HEX schedules two (or three daily doses) improved average and total 24-hour growth hormone levels to an equivalent extent. The enhancement was due to enhanced GH concentrations, not from more frequent ones. HEX also prolonged GH half-life in the blood sugar and modified the GH to release hormone synthase pattern more.

Another trial tested how hexarelin, a synthetic peptide that strongly increases growth hormone (GH), affects GH release in eight healthy men aged 21–33 years. Each participant received a single bolus injection of hexarelin (2 micrograms per kilogram) or saline (placebo), both in the morning (8–9 a.m.) after fasting and during sleep (11 p.m.–12 a.m.), in random order.

Blood samples were taken before and every 15 minutes for 2 hours after each injection. GH levels were measured to find peak values and the area under the curve (AUC), showing total GH released.

The study found that peak GH levels after hexarelin were almost the same in the morning (58.2 ± 4.7 μg/L) and during sleep (61.2 ± 4.3 μg/L). However, GH stayed in the blood much longer during sleep (half-life 64.9 ± 14.8 minutes) than in the morning (24.9 ± 1.4 minutes, P < 0.01). The total GH output (AUC) was also significantly higher during sleep (1466 ± 145 μg·min/L) compared to the morning (903 ± 94 μg·min/L, P < 0.001).

 

3. Mechanism & Effects 

Hexarelin binds strongly to GHS-R1a, enhancing GH secretion and increasing downstream IGF-1 levels. Beyond GH release, it shows protective actions on heart muscle cells, improving heart function and reducing damage from oxidative stress. Animal studies also suggest Hexarelin may help preserve bone density and promote lean body mass.

 

4. Safety & Considerations  

Clinical data show Hexarelin is generally well-tolerated. No serious adverse effects were reported in short-term studies. Some subjects experienced mild increases in prolactin and cortisol, which normalized after discontinuation. Long-term studies are limited, so extended use should be approached cautiously.

Additional research notes that Hexarelin’s safety profile remains favorable even with repeated dosing over short treatment periods. Temporary hormonal shifts such as elevated GH, prolactin, and cortisol are typically mild and reversible. Participants in controlled trials did not exhibit cardiac or metabolic complications, and no withdrawal symptoms were observed after stopping the peptide.

 

References

Bowers CY, et al. Hexarelin stimulates growth hormone release in healthy men. J Clin Endocrinol Metab. 1995.

Ghigo E, et al. Endocrine and metabolic effects of Hexarelin in elderly subjects. Eur J Endocrinol. 1998.

Locatelli V, et al. Cardioprotective properties of Hexarelin in patients with cardiac dysfunction. J Endocrinol Invest. 2000.

 

You ask,
we answer.